Transient myeloproliferative syndrome in neonates with Down syndrome. Overview and analysis of 115 patients from the AML-BFM and ESPED studies;Transitorisch myeloproliferatives syndrom bei neugeborenen mit Down-syndrom. Überblick und analyse von 115 patienten aus den AML-BFM-studien und der ESPED-studie

Monatsschrift fur Kinderheilkunde

Volumn 154, Issue 2, 2006, Pages 162-168

  Diekamp, S ^a,b   Creutzig, U ^a   Reinhardt, D ^a   Baumann Kohler M ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Klin/Poliklin fur Kinderheilkunde   (Germany)

Author keywords

Down syndrome; Liver fibrosis; Therapy; Transient myeloproliferative syndrome

Indexed keywords

CYTARABINE;

ACUTE MYELOBLASTIC LEUKEMIA; ANEMIA; ARTICLE; BLOOD; BONE MARROW CELL; CELL PROLIFERATION; CHILD; CLINICAL FEATURE; DISEASE COURSE; DISEASE DURATION; DOWN SYNDROME; ERYTHROBLAST; FOLLOW UP; HEPATOMEGALY; HUMAN; HYPERLEUKOCYTOSIS; INCIDENCE; LETHALITY; LEUKOCYTOSIS; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MEGAKARYOBLAST; MYELOPROLIFERATIVE DISORDER; NEWBORN; NEWBORN DISEASE; REMISSION; RISK FACTOR; THROMBOCYTOPENIA; TRANSIENT MYELOPROLIFERATIVE SYNDROME; TREATMENT INDICATION;

EID: 33344462105     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00112-004-1016-y     Document Type: Article

References (32)

1. Al Kasim F, Doyle JJ, Massey GV et al. (2002) Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study. J Pediatr Hematol Oncol 24:9-13
2. Becroft DM (1993) Fetal megakaryocytic dyshemopoiesis in Down syndrome: association with hepatic and pancreatic fibrosis. Pediatr Pathol 13:811-820
3. Becroft DM, Zwi LJ (1990) Perinatal visceral fibrosis accompanying the megakaryoblastic leukemoid reaction of Down syndrome. Pediatr Pathol 10:397-406
4. Bonno M, Azuma E, Kawasaki H et al. (1998) Thrombopoietin level is inversely related to blast count, not platelet number, in Down syndrome neonates with transient myeloproliferative disorder. Am J Hematol 58:267-272
5. Creutzig U, Baumann M (1998) Spontaneous remission in neonates with Down's syndrome and Acute Myelogenous Leukemia - Transient Myeloproliferative Disease. Onkologie 21:184-188
6. Creutzig U, Ritter J, Ludwig WD et al. (1995) Acute myeloid leukemia in children with Down syndrome. Klin Padiatr 207:136-144
7. Creutzig U, Ritter J, Niemeyer C et al. (1997) Down's syndrome and megakaryoblastic leukemia. Haematol Blood Transfus 38:754-760
8. Creutzig U, Ritter J, Vormoor J et al. (1996) Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group. Leukemia 10:1677-1686
9. Fong CT, Brodeur GM (1987) Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genet Cytogenet 28:55-76
10. Gamis AS, Hilden JM (2002) Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia? J Pediatr Hematol Oncol 24:2-5
11. Hanna MD, Melvin SL, Dow LW et al. (1985) Transient myeloproliferative syndrome in a phenotypically normal infant. Am J Pediatr Hematol Oncol 7:79-81
12. Hasle H (2001) Pattern of malignant disorders in individuals with Down's syndrome. Lancet Oncol 2:429-436
13. Hattori H, Matsuzaki A, Suminoe A et al. (2001) High expression of platelet-derived growth factor and transforming growth factor-beta 1 in blast cells from patients with Down Syndrome suffering from transient myeloproliferative disorder and organ fibrosis. Br J Haematol 115:472-475
14. Hitzler JK, Cheung J, Li Y et al. (2003) GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood 101:4301-4304
15. Hongeng S, Pakakasama S, Hathirat P et al. (2000) Diffuse hepatic fibrosis with transient myeloproliferative disorders in Down syndrome. J Pediatr Hematol Oncol 22:543-544
16. Hoskote A, Chessells J, Pierce C (2002) Transient abnormal myelopoiesis (TAM) causing multiple organ failure. Intensive Care Med 28:758-762
17. Karandikar NJ, Aquino DB, McKenna RW et al. (2001) Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis. Am J Clin Pathol 116:204-210
18. Krivit W, Good RA (1957) Simultaneous occurrence of mongolism and leukemia. Am J Dis Child 94:193-289
19. Lange B (2000) The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. Br J Haematol 110:512-524
20. Lange BJ, Kobrinsky N, Barnard DR et al. (1998) Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891. Blood 91:608-615
21. Miyauchi J, Ito Y, Kawano T et al. (1992) Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: a report of four autopsy cases and proposal of a hypothesis. Blood 80:1521-1527
22. Mundschau G, Gurbuxani S, Gamis AS et al. (2003) Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis. Blood 101:4298-4300
23. Polski JM, Galambos C, Gale GB et al. (2002) Acute megakaryoblastic leukemia after transient myeloproliferative disorder with clonal karyotype evolution in a phenotypically normal neonate. J Pediatr Hematol Oncol 24:50-54
24. Rainis L, Bercovich D, Strehl S et al. (2003) Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood 102:981-986
25. Ravindranath Y, Abella E, Krischer JP et al. (1992) Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood 80:2210-2214
26. Rizzari C, Malberti R, Dell'Orto M et al. (1999) Transient myeloproliferative disorder associated with trisomy 21: is a short course of chemotherapy indicated in patients with liver impairment and severe clinical problems? Med Pediatr Oncol 32:453-454
27. Schwab M, Niemeyer C, Schwarzer U (1998) Down syndrome, transient myeloproliferative disorder, and infantile liver fibrosis. Med Pediatr Oncol 31:159-165
28. Taub JW, Ravindranath Y (2002) Down syndrome and the transient myeloproliferative disorder: why is it transient? J Pediatr Hematol Oncol 24:6-8
29. Wechsler J, Greene M, McDevitt MA et al. (2002) Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet 32:148-152
30. Xu G, Nagano M, Kanezaki R et al. (2003) Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome. Blood 102:2960-2968
31. Zipursky A, Brown E, Christensen H et al. (1997) Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome. Semin Perinatol 21:97-101
32. Zipursky A, Poon A, Doyle J (1992) Leukemia in Down syndrome: a review. Pediatr Hematol Oncol 9:139-149